A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity
Yufan Jian,1,2,* Meina Zhao,1,2,* Jinyi Cao,1,* Tingting Fan,1 Wei Bu,1 Yang Yang,3 Weiwei Li,1 Wei Zhang,1 Yi Qiao,1 Jingwen Wang,1 Aidong Wen1,2 1Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi’an 710032, People’s Republic of China; 2College...
Main Authors: | Jian Y, Zhao M, Cao J, Fan T, Bu W, Yang Y, Li W, Zhang W, Qiao Y, Wang J, Wen A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/a-gastric-cancer-peptide-gx1-modified-nano-lipid-carriers-encapsulatin-peer-reviewed-article-DDDT |
Similar Items
-
Study of SOX combined with intraperitoneal high‐dose paclitaxel in gastric cancer with synchronous peritoneal metastasis: A phase II single‐arm clinical trial
by: Li Tu, et al.
Published: (2023-02-01) -
Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial
by: Fushida S, et al.
Published: (2016-07-01) -
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer
by: Shen Zhao, et al.
Published: (2022-09-01) -
Ramucirumab combined with paclitaxel as the second-line chemotherapy for elderly patients with disseminated gastric cancer
by: T. A. Titova, et al.
Published: (2018-07-01) -
Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes
by: Li K, et al.
Published: (2017-12-01)